F

Formation Bio

AI-driven platform accelerates clinical-stage drug development

Director of Financial Reporting

Financial AccountingConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • Hold a CPA credential.
  • Have ten or more years of progressive accounting experience, including direct responsibility for preparing audited US GAAP financial statements and footnotes and supporting an external audit.
  • Have experience in technical accounting, preferably within an in-house corporate accounting group.
  • Demonstrate the ability to convert complex accounting guidance into practical calculations, journal entries, disclosures, and repeatable processes, including experience with consolidations (including VIEs), noncontrolling interests and other ASC 810 issues, financial instruments, liability and equity accounting, share-based compensation, revenue recognition, ASC 820 fair value, licensing and collaboration arrangements, leases, capitalized software, and R&D-related accounting.
  • Have experience consolidating a complex organizational structure.
  • Be able to prepare clear, concise technical accounting memoranda and organized, audit-ready workpapers and financial statement support.
  • Be able to run multiple reporting and audit workstreams simultaneously, work independently at detailed and strategic levels, and constructively challenge auditors, consultants, and internal stakeholders.
  • Have experience with NetSuite or a comparable ERP and strong spreadsheet skills.

Responsibilities

  • Own preparation of annual US GAAP financial statements, including footnotes, disclosures, supporting workpapers, calculations, and tie-outs.
  • Own the financial reporting process, including coordination of cross-functional stakeholders.
  • Prepare supporting analysis for board reporting and investor and data-room financial information requests.
  • Prepare and review manual, non-routine, and period-end journal entries arising from non-routine transactions.
  • Determine and document non-routine or judgmental accounting transactions, including accruals, stock-based compensation, and other judgmental transactions.
  • Lead the consolidation process and entries for a complex organizational structure, including application of ASC 810.
  • Review complex account reconciliations and related close documentation.
  • Translate new business activity and accounting conclusions into operational close processes and implement them.
  • Lead year-end general-ledger preparation for audit.
  • Assist in preparing technical accounting analysis for complex transactions and accounting matters, and write technical accounting memoranda.
  • Convert approved technical accounting conclusions into calculations, workpapers, journal entries, disclosures, and recurring processes, and ensure the conclusions are reflected properly in the books and records.
  • Implement and maintain accounting for financial instruments, equity issuances, share-based compensation, noncontrolling interests and other ASC 810 matters, leases, licensing transactions, and other business development transactions.
  • Prepare the accounting policy manual and document accounting policy decisions.
  • Serve as the day-to-day contact for external auditors, coordinate audit requests, gather information, and manage the flow of information and support to auditors.
  • Respond to audit inquiries and escalate significant and technical matters.
  • Assemble audit-ready workpapers and support packages for financial statements, footnotes, complex entries, and other significant accounting areas.
  • Support resolution and remediation of audit findings.
  • Support reporting and accounting for the company’s special-purpose financial statements serviced by a third-party fund administrator.
  • Support capital call and capital transaction accounting.
  • Establish policy and resolve and document accounting issues related to special-purpose financial statements, coordinating with the third-party fund administrator.
  • Review and comment on fund financial statements and reconcile administrator reporting to internal records.
  • Coordinate the fund’s annual audit with the corporate audit timeline.
  • Establish and maintain controls around complex and non-routine transactions.
  • Improve internal controls and related documentation for significant accounting and reporting processes, as well as the quality of support for significant accounting areas.
  • Establish audit-ready documentation as a standing practice.
  • Provide execution capacity on complex, ongoing accounting processes, including those arising from business development activity and other non-routine transactions.
  • Work with Legal, Business Development, R&D, and Clinical Operations to understand new contracts, arrangements, and study activity and reflect them accurately in accounting records.
  • Build capabilities and provide training across the Finance team to improve the quality and effectiveness of Finance output.

Desired Qualifications

  • Big Four or comparable public accounting experience is strongly preferred.
  • Biotechnology, pharmaceutical, or broader life sciences experience is preferred.

About the Company

Formation Bio

AI-driven platform accelerates clinical-stage drug development

Formation Bio uses an AI-driven platform to speed up drug development by focusing on clinical-stage assets. It acquires and advances these assets using flexible financing structures, aiming to shorten timelines and cut costs for bringing new drugs to market. The core product is the proprietary AI tools that help with drug selection, development planning, and improving overall efficiency, enabling partnerships and successful commercialization with pharmaceutical and biotech companies. Compared with competitors, Formation Bio combines a data-powered approach with adaptable financing and asset acquisition strategies to move assets forward quickly and cost-effectively. The goal is to make treatments more accessible and affordable by accelerating development and enabling faster, more predictable commercialization through AI-enhanced decision making and flexible funding options.

Company size
51-200
Company stage
Series D
Total funding
$530.3M
Headquarters
New York City, New York
Founded
2013

Recently Posted Jobs

Explore more opportunities at Formation Bio

See more jobs